Skip to main content
. 2022 Mar 10;13(5):585–593. doi: 10.1039/d1md00387a

Cytotoxicity assay and MIC against clinical isolates of DR-Mtb strains of selected compounds.

Compound code MIC (μg mL−1) Cytotoxicity
Mtb H37Rv ATCC 27294 Mtb INH-resa ATCC 35822 Mtb ETB-resa ATCC 35837 Mtb STR-resa ATCC 35820 Mtb RIF-resa ATCC 35838 Vero cell CC50 (μg mL−1) SIb
5o 0.5 2 2 1 2 >50 >100
9a 0.03 0.25 0.03 0.03 0.03 >10 >320
9b 0.12 0.25 0.06 0.25 0.06 >20 >160
9c 0.03 0.12 0.03 0.03 0.03 >2.5 >80
9d 0.06 0.25 0.06 0.06 0.06 >40 >640
INH 0.03 >64 0.03 0.03 0.03 n.d. n.d.
RIF 0.06 0.03 0.03 0.03 64 n.d. n.d.
STR 1 1 1 >64 1 n.d. n.d.
ETB 2 4 32 2 2 n.d. n.d.
a

INH-res: isoniazid-resistant; ETB-res: ethambutol-resistant; STR-res: streptomycin-resistant; RIF-res: rifampicin-resistant.

b

Selectivity index = CC50/MIC; n.d.: not determined.